Anixa Biosciences, Inc.
ANIX
$2.58
-$0.08-3.01%
NASDAQ
| 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -12.48M | -12.55M | -12.36M | -11.60M | -10.74M |
| Total Depreciation and Amortization | 33.00K | 37.00K | 40.00K | 48.00K | 48.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.21M | 4.66M | 4.88M | 4.82M | 4.81M |
| Change in Net Operating Assets | 315.00K | 526.00K | -935.00K | -453.00K | -644.00K |
| Cash from Operations | -7.93M | -7.34M | -8.38M | -7.18M | -6.53M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 6.85M | 4.28M | 2.82M | -888.00K | -4.89M |
| Cash from Investing | 6.85M | 4.28M | 2.82M | -888.00K | -4.89M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1.19M | 1.25M | 1.53M | 1.34M | 430.00K |
| Repurchase of Common Stock | -33.00K | -33.00K | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -17.00K | 2.20M | 2.06M | 2.10M | 2.20M |
| Cash from Financing | 1.14M | 3.42M | 3.59M | 3.44M | 2.63M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 55.00K | 356.00K | -1.97M | -4.63M | -8.79M |